VCP and osteosarcoma: Additionally, USP2, recruited by VCP, enhances the stability of fatty acid synthase (FASN) by removing K48−linked ubiquitin chains, a process whose inhibition reverses pro-tumorigenic effects in osteosarcoma cells (289).